Search hospitals > New York > New Hyde Park
Don Monti Comprehensive Cancer Center at North Shore University Hospital
Claim this profileNew Hyde Park, New York 11042
Global Leader in Leukemia
Global Leader in Lung Cancer
Conducts research for Breast Cancer
Conducts research for Lymphoma
Conducts research for Cancer
99 reported clinical trials
5 medical researchers
Summary
Don Monti Comprehensive Cancer Center at North Shore University Hospital is a medical facility located in New Hyde Park, New York. This center is recognized for care of Leukemia, Lung Cancer, Breast Cancer, Lymphoma, Cancer and other specialties. Don Monti Comprehensive Cancer Center at North Shore University Hospital is involved with conducting 99 clinical trials across 115 conditions. There are 5 research doctors associated with this hospital, such as Veena John, MD, Marina Frimer, MD, Joanna Rhodes, MD, and Kevin M. Sullivan.Area of expertise
1Leukemia
Global LeaderFLT3 positive
2Lung Cancer
Global LeaderStage IV
EGFR
Stage III
Top PIs
Veena John, MDNorthwell Health/Center for Advanced Medicine1 year of reported clinical research
Studies Ovarian Cancer
Studies Ovarian Tumors
12 reported clinical trials
23 drugs studied
Marina Frimer, MDNorthwell Health4 years of reported clinical research
Studies Endometrial Cancer
Studies Endometrioid Carcinoma
6 reported clinical trials
28 drugs studied
Joanna Rhodes, MDNorthwell Health/Center for Advanced Medicine3 years of reported clinical research
Studies Lymphoma
Studies Follicular Lymphoma
6 reported clinical trials
16 drugs studied
Kevin M. SullivanNorthwell Health Imbert Cancer Center3 years of reported clinical research
Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
5 reported clinical trials
13 drugs studied
Clinical Trials running at Don Monti Comprehensive Cancer Center at North Shore University Hospital
Follicular Lymphoma
Bladder Cancer
Non-Hodgkin's Lymphoma
Blood Cancers
Solid Tumors
Lymphoma
Autoimmune Hemolytic Anemia
Renal Cell Carcinoma
Kidney Cancer
Cancer
Tazemetostat + Lenalidomide + Rituximab
for Follicular Lymphoma
The participants of this study would have relapsed/refractory follicular lymphoma. Follicular lymphoma is a type of blood cancer. It is referred to as 'relapsed' when the disease has come back after a period of improvement after that follows a treatment regimen and 'refractory' when treatment no longer works. Stage 1 of this trial will study the safety and the level that adverse effects of each of the study drug combinations can be tolerated (known as tolerability). It is also designed to establish a recommended study drug dosage for stage 2 and 3. Stage 1 of the study is completed. Stages 2 and 3 will evaluate and compare how long participants live without their disease getting worse when receiving the study drug in combination with other drug treatment versus the placebo (dummy drug) in combination with other drug treatment.
Recruiting1 award Phase 34 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Don Monti Comprehensive Cancer Center at North Shore University Hospital?
Don Monti Comprehensive Cancer Center at North Shore University Hospital is a medical facility located in New Hyde Park, New York. This center is recognized for care of Leukemia, Lung Cancer, Breast Cancer, Lymphoma, Cancer and other specialties. Don Monti Comprehensive Cancer Center at North Shore University Hospital is involved with conducting 99 clinical trials across 115 conditions. There are 5 research doctors associated with this hospital, such as Veena John, MD, Marina Frimer, MD, Joanna Rhodes, MD, and Kevin M. Sullivan.